Neurodevelopmental Outcomes After Novel Interventions In Newborn Infants
Funder
National Health and Medical Research Council
Funding Amount
$188,226.00
Summary
Children who were sick in the newborn period or born preterm are at increased risk of abnormal development, particularly problems with their ability to walk, think and learn. This research will assess how new treatments affect sick newborns’ later development. For example, giving preterm babies healthy germs, or probiotics, decreases a serious bowel infection, called necrotising enterocolitis or NEC. This research will find out if they also help preterm brain development when the children are 2 ....Children who were sick in the newborn period or born preterm are at increased risk of abnormal development, particularly problems with their ability to walk, think and learn. This research will assess how new treatments affect sick newborns’ later development. For example, giving preterm babies healthy germs, or probiotics, decreases a serious bowel infection, called necrotising enterocolitis or NEC. This research will find out if they also help preterm brain development when the children are 2 years old.Read moreRead less
A Multicentre Randomised Controlled Trial Of Probiotic And Peanut Oral Immunotherapy For The Treatment Of Peanut Allergy
Funder
National Health and Medical Research Council
Funding Amount
$2,887,302.00
Summary
A curative treatment for food allergy is required to prevent deaths and improve management. We recently trialed a new treatment for peanut allergy that was highly effective. Over 80% of children treated with Probiotic and Peanut Oral ImmunoTherapy (PPOIT) tolerated peanut as compared to 4% of children who received placebo. We now plan a larger multicentre trial to confirm these findings. If successful, we will have established a new treatment for peanut allergy and possibly all food allergies.
Curing Antibiotic Resistance: Probiotic Plasmids And Microbial Husbandry In The Enterobacteriaceae
Funder
National Health and Medical Research Council
Funding Amount
$560,832.00
Summary
The most troublesome emerging antibiotic resistance is coming in the form of addictive and promiscuous 'pest' plasmids, carrying dangerous genes that defeat antibiotics used for the most severe infections. We currently manage this problem by isolating infected patients and trying to design new antibiotics. Our approach eradicates these plasmids and renders the host bacterium antibiotic susceptible again, thereby restoring the natural ecology in animals and potentially in humans.
Prevention Of Otitis Media With Probiotics In Indigenous Children
Funder
National Health and Medical Research Council
Funding Amount
$100,531.00
Summary
The project is searching for ‘good’ bacteria in the upper airways of Aboriginal and Torres Strait Islander (A&TSI) children that have the ability to inhibit the growth of bacteria that causes middle ear disease. These ‘good’ bacteria constitute a possible probiotic and will be matched to commercially available probiotic strains. These probiotic strains will then be used to recolonise the upper airways of A&TSI children to determine whether we can reduce the recurrence of middle ear disease.
The Effect Of Probiotics On The Neurodevelopmental Outcomes Of Preterm Infants
Funder
National Health and Medical Research Council
Funding Amount
$1,068,804.00
Summary
Premature infants are at increased risk of abnormal development, meaning problems with their ability to walk, talk, think, hear and see. Giving premature babies ‘good bacteria’ (probiotics) may help them survive, but little is known about how probiotics affect long-term development. This is the first large study to assess the development of children who were involved in a trial of probiotics following their premature birth.
Faecal Microbiota Transplantation And Other Novel Therapeutic Microbial Manipulation Strategies In Inflammatory Bowel Disease
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
There is growing interest in the role of microbial-based strategies including faecal microbiota transplantation (FMT) for the treatment of inflammatory bowel disease. This project will develop such strategies into valid treatment options through a combination of clinical & basic science work including (1) characterising viral & fungal factors of importance, (2) evaluation of novel orally-delivered formulations of FMT, and (3) development of better defined, more reproducible microbial treatments.